EurekaMag
+ Translate
+ Most Popular
The pigeon tick (Argas reflexus): its biology, ecology, and epidemiological aspects
Prevalence of hemoglobin abnormalities in Kebili (Tunisian South)
Lipogranuloma: a preventable complication of dacryocystorhinostomy
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
Bees from the Belgian Congo. The acraensis group of Anthophora
Placing gingival retraction cord
Total serum IgE, allergy skin testing, and the radioallergosorbent test for the diagnosis of allergy in asthmatic children
Acariens plumicoles Analgesoidea parasites des oiseaux du Maroc
Injuries of terminal phalanges of the fingers in children
Biology of flowering and nectar production in pear (Pyrus communis)
Das Reliktvorkommen der Aspisviper (Vipera aspis L.) im Schwarzwald
Hydrological modelling of drained blanket peatland
Pathologic morphology and clinical significance of the anomalous origin of the left circumflex coronary artery from the right coronary artery. General review and autopsy analysis of 30 cases
Cyto genetic analyses of lymphocyte cultures after exposure to calcium cyclamate
Axelrodia riesei, a new characoid fish from Upper Rio Meta in Colombia With remarks concerning the genus Axelrodia and description of a similar, sympatric, Hyphessobrycon-species
Favorable evolution of a case of tuberculosis of pancreas under antibiotic action
RIFM fragrance ingredient safety assessment, Valencene, CAS Registry Number 4630-07-3
Parenteral microemulsions: an overview
Temperate pasture: management for grazing and conservation
Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation
Thermal expansion and cracking of three confined water-saturated igneous rocks to 800C
Revision of the genera of the tribe Stigmoderini (Coleoptera: Buprestidae) a discussion of phylogenetic relationships
Anal tuberculosis. Report of a case
Gastric tuberculosis in the past and present
Adaptive responses of the cardiovascular system to prolonged spaceflight conditions: assessment with Holter monitoring

Effects of foods on the pharmacokinetics and clinical efficacy of quazepam


Effects of foods on the pharmacokinetics and clinical efficacy of quazepam



Nihon Shinkei Seishin Yakurigaku Zasshi 23(5): 205-210



ISSN/ISBN: 1340-2544

PMID: 14653226

The effects of foods on the pharmacokinetics and clinical efficacy of quazepam, a benzodiazepine derivative, in healthy persons were examined. Six healthy Japanese male subjects were randomly divided into three groups and each subject was treated with quazepam under the following three conditions by the crossover method. For the fasting state, subjects were administered 15 mg quazepam 11 hours after a meal. For the postprandial state, subjects were administered 15 mg or 30 mg quazepam 2 hours after a meal. Mean peak plasma concentration (Cmax) of quazepam was significantly higher (1.6-2.8 fold) with administration 2 hours after a meal than 11 hours after a meal. However, in regard to 15 mg of quazepam administration, the area under the curve (AUC) did not differ between administration 2 hours after a meal and 11 hours after a meal. In addition, differences were observed neither in other pharmacokinetic parameters or blood metabolite concentration under all of the study conditions, nor in clinical evaluation of subjective symptoms, complete blood count, or biochemical analyses between administrations 2 and 11 hrs after a meal. The present study showed that administration 2 hours after a meal did not affect subjective symptoms or physical functions so much; therefore it suggested favorable tolerance of this drug. However, it was also suggested that, in actual clinical use, it is important to evaluate the physical function including measurements of vital signs and hematological test results, carefully considering the effects of foods and daily life-style.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 012015294

Download citation: RISBibTeXText

Related references

Liquid chromatographic assay and pharmacokinetics of quazepam and its metabolites following sublingual administration of quazepam. Pharmaceutical Research 5(6): 365-368, 1988

Time effects of food intake on the pharmacokinetics and pharmacodynamics of quazepam. British Journal of Clinical Pharmacology 55(4): 382-388, 2003

Different effects of light food on pharmacokinetics and pharmacodynamics of three benzodiazepines, quazepam, nitrazepam and diazepam. Journal of Clinical Pharmacy and Therapeutics 32(1): 31-39, 2007

Quazepam: hypnotic efficacy and side effects. PharmacoTherapy 10(1): 1-10; Discussion 10-2, 1990

Selective affinity of the benzodiazepines quazepam and 2-oxo-quazepam for BZ1 binding site and demonstration of 3H-2-oxo-quazepam as a BZ1 selective radioligand. Life Sciences 42(2): 179-187, 1988

Clinical considerations on the efficacy and tolerability of a new sleep-inducing benzodiazepine for elderly patients: quazepam. La Clinica Terapeutica 120(3): 227-236, 1987

Effect of St Johns Wort on the pharmacokinetics and pharmacodynamics of quazepam. Clinical Pharmacology and Therapeutics 73(2): P44, 2003

Effect of dietary fat content in meals on pharmacokinetics of quazepam. Journal of Clinical Pharmacology 42(12): 1335-1340, 2002

Single oral dose pharmacokinetics of quazepam is influenced by CYP2C19 activity. Therapeutic Drug Monitoring 26(5): 529-533, 2004

Oxprenolol hydrochloride: pharmacology, pharmacokinetics, adverse effects and clinical efficacy. PharmacoTherapy 3(2 Pt 1): 68-81, 1983

Longitudinal study on pharmacodynamics and pharmacokinetics of acute, steady-state and withdrawn quazepam. Arzneimittel-Forschung 39(2): 276-283, 1989

The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis. Expert Opinion on Drug Delivery 17(4): 523-541, 2020

Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects. PharmacoTherapy 5(3): 109-126, 1985

Cefonicid: a long-acting, second-generation cephalosporin. Antimicrobial activity, pharmacokinetics, clinical efficacy and adverse effects. PharmacoTherapy 4(6): 325-333, 1984

Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects. PharmacoTherapy 4(6): 297-307, 1984